Form 4 for BHVN Biohaven Ltd.
Accepted 2024-03-08 00:00:00 ET · period of report 2024-03-08 · accession 0001562180-24-002510 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-03-08 | 2024-03-08 | BHVN | CHILDS JOHN W | Dir | A - Grant | — | +19.4K | 2.18M | +0.9% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-03-08 | A | A | 19,412 | — | 2,179,580 | I By John W Childs 2013 Revocable Trust | — | — | (F1) Pursuant to an agreement and plan of merger, dated as of January 7, 2024, common shares of the Issuer were issued to the Reporting Person on March 8, 2024. The acquisition of the acquired company pursuant to the agreement and plan of merger and the issuance of common shares of the Issuer to the Reporting Person in connection therewith were approved by the Board of the Issuer pursuant to Rule 16b-3. |